Researchers test if Real-World data can replicate major diabetes trial

This study looks at health insurance claims from about 30,000 people with type 2 diabetes to see if real-world data can produce similar results to a large clinical trial called REWIND. The goal is to learn when and how to trust real-world data for answering medical questions. No new treatments are given; instead, researchers analyze existing records to compare two diabetes drugs, dulaglutide and sitagliptin.